Zobrazeno 1 - 10 of 779 pro vyhledávání: '"Dresser MJ"'
1
Akademický článek
A guide to developing population files for physiologically‐based pharmacokinetic modeling in the Simcyp Simulator.
Autor: Curry, Liam1 (AUTHOR) liam.curry@certara.com, Alrubia, Sarah2,3 (AUTHOR), Bois, Frederic Y.1 (AUTHOR), Clayton, Ruth1 (AUTHOR), El‐Khateeb, Eman1,4 (AUTHOR), Johnson, Trevor N.1 (AUTHOR), Faisal, Muhammad1 (AUTHOR), Neuhoff, Sibylle1 (AUTHOR), Wragg, Kris1 (AUTHOR), Rostami‐Hodjegan, Amin1,2 (AUTHOR)
Publikováno v: CPT: Pharmacometrics & Systems Pharmacology. Sep2024, Vol. 13 Issue 9, p1429-1447. 19p.
Zobrazit plný text záznamu
2
Akademický článek
Tipifarnib physiologically‐based pharmacokinetic modeling to assess drug–drug interaction, organ impairment, and biopharmaceutics in healthy subjects and cancer patients.
Autor: Okudaira, Noriko1 (AUTHOR), Burt, Howard1 (AUTHOR), Mitra, Amitava2 (AUTHOR) amitra@kuraoncology.com
Publikováno v: CPT: Pharmacometrics & Systems Pharmacology. Aug2024, Vol. 13 Issue 8, p1366-1379. 14p.
Zobrazit plný text záznamu
3
Akademický článek
An open‐label study to explore the optimal design of CYP3A drug–drug interaction clinical trials in healthy Chinese people.
Autor: Chen, Jingcheng1, Li, Jiangshuo1, Wu, Jingxuan1, Song, Yuqin1, Li, Lijun1, Zhang, Jianxiong1, Dong, Ruihua1 rui_hua_dong_rw@163.com
Publikováno v: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-9. 9p.
Zobrazit plný text záznamu
4
Akademický článek
The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first‐in‐class ACKR3/CXCR7 antagonist, ACT‐1004‐1239.
Autor: Huynh, Christine1,2 (AUTHOR), Dingemanse, Jasper1 (AUTHOR), Meyer zu Schwabedissen, Henriette E.2 (AUTHOR), Fonseca, Marlene3 (AUTHOR), Sidharta, Patricia N.1 (AUTHOR) patricia.sidharta@idorsia.com
Publikováno v: CTS: Clinical & Translational Science. Jul2024, Vol. 17 Issue 7, p1-10. 10p.
Zobrazit plný text záznamu
5
Akademický článek
Bioequivalence Assessment of Two Dapoxetine Hydrochloride Formulations in Healthy Chinese Males Under Fasted and Fed Conditions.
Autor: Li Y; Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.; School of Chemical Engineering, Xuzhou Vocational College of Industrial Technology, Xuzhou, China., Zhang Z; Shandong Hubble Kisen Biological Technology CO., Ltd., Jinan, China., Xie J; Shandong Center for Food and Drug Evaluation and Inspection, Jinan, China., Lian X; Shandong Hubble Kisen Biological Technology CO., Ltd., Jinan, China., Zhang G; Shandong Hubble Kisen Biological Technology CO., Ltd., Jinan, China., Wang C; Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.; Laboratory for Marine Drugs and Bioproducts, Pilot National Laboratory for Marine Science and Technology, Qingdao, China.
Publikováno v: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Aug; Vol. 13 (8), pp. 861-869. Date of Electronic Publication: 2024 Feb 23.
Zobrazit plný text záznamu
6
Akademický článek
Evaluation of the drug–drug interaction potential of brigatinib using a physiologically‐based pharmacokinetic modeling approach.
Autor: Hanley, Michael J.1 (AUTHOR), Yeo, Karen Rowland2 (AUTHOR), Tugnait, Meera3 (AUTHOR), Iwasaki, Shinji4 (AUTHOR), Narasimhan, Narayana5 (AUTHOR), Zhang, Pingkuan6 (AUTHOR), Venkatakrishnan, Karthik7 (AUTHOR), Gupta, Neeraj1 (AUTHOR) neeraj.gupta@takeda.com
Publikováno v: CPT: Pharmacometrics & Systems Pharmacology. Apr2024, Vol. 13 Issue 4, p624-637. 14p.
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
A clinical drug-drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor on the pharmacokinetics of vismodegib.
Autor: Malhi V; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. vmalhi@gmail.com., Colburn D; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Williams SJ; F. Hoffmann-La Roche, Ltd., Welwyn Garden City, UK., Hop CE; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Dresser MJ; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.; Denali Therapeutics, South San Francisco, CA, USA., Chandra P; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Graham RA; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.; Theravance Biopharma, South San Francisco, CA, USA.
Publikováno v: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Jul; Vol. 78 (1), pp. 41-9. Date of Electronic Publication: 2016 May 06.
Zobrazit plný text záznamu
10
Akademický článek
Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies.
Autor: Liu L; Genentech Inc., South San Francisco, CA, USA., Bello A; Bristol-Myers Squibb, Princeton, NJ, USA., Dresser MJ; Genentech Inc., South San Francisco, CA, USA., Heald D; Janssen Research and Development, Spring House, PA, USA., Komjathy SF; Eli Lilly and Company, Indianapolis, IN, USA., O'Mara E; Celgene Corp., Summit, NJ, USA., Rogge M; Biogen, Inc., Cambridge, MA, USA., Stoch SA; Merck Sharp & Dohme Corp., Lansdale, PA, USA., Robertson SM; Vertex Pharmaceuticals Inc., Boston, MA, USA.
Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2016 Feb; Vol. 56 (2), pp. 143-51. Date of Electronic Publication: 2015 Jul 29.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje